HOME
ABOUT US
OUR COMPANY
OUR TEAM
BOARD OF DIRECTORS
INVESTORS
CAREERS
T-GUARD®
CHARACTERISTICS
DEVELOPMENT PLAN
GRAFT-VERSUS-HOST
ADDITIONAL INDICATIONS
EXPANDED ACCESS
A PATIENT’S STORY
NEWS & EVENTS
NEWS
EVENTS
IN THE MEDIA
PUBLICATIONS
PARTNERING
PARTNERING FOR PROGRESS
CONTACT
2018
Filter by
Languages
Skill level
Authors
Show all
All
Press-releases
All
2021
2019
2018
2017
2016
2015
2014
2013
2012
All
Carrie McKim
Jeroen Schumacher
MauriceHampsink
Ypke van Oosterhout
20 december 2018
20 december 2018
Xenikos partners with the BMT CTN to conduct a U.S.-based Phase 3 trial to test T-Guard® in aGVHD
16 november 2018
16 november 2018
Final results from T-Guard® Phase 1/2 trial in steroid-resistant aGVHD published in journal BBMT
14 mei 2018
14 mei 2018
Dutch Company Xenikos Secures USD 30 Million in Series B Financing
